Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates

Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +13.39%. A quarter ago, it was expected that this company would post a loss of $0.28 per share when it actually produced a loss of $0.32, delivering a surprise of -14.29%.Over the last four quarters, the company has ...